Search Results - "Moreira, Débora A"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease by Moreira, Débora A, Santos, Sofia D, Leiro, Victoria, Pêgo, Ana P

    Published in Pharmaceutics (24-03-2023)
    “…Alzheimer's disease (AD) is the most prevalent form of dementia. It affects more than 30 million people worldwide and costs over US$ 1.3 trillion annually. AD…”
    Get full text
    Journal Article
  2. 2

    PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia by Santos, Sofia D., Xavier, Miguel, Leite, Diana M., Moreira, Débora A., Custódio, Beatriz, Torrado, Marília, Castro, Rita, Leiro, Victoria, Rodrigues, João, Tomás, Helena, Pêgo, Ana P.

    Published in Journal of controlled release (10-12-2018)
    “…Drug delivery to the central nervous system is restricted by the blood-brain barrier (BBB). However, with the onset of stroke, the BBB becomes leaky, providing…”
    Get full text
    Journal Article
  3. 3

    Simple and rapid determination of clonidine in pharmaceutical samples by voltammetry using a bare glassy carbon electrode by Moreira, Débora A. R., Pimentel, Dilton M., Arrieiro, Mariane O. B., Barbosa, Sandro L., Silva, Rodrigo A. B., Santos, Wallans T. P.

    Published in Electroanalysis (New York, N.Y.) (01-05-2023)
    “…This work presents, for the first time, the voltammetric behavior of clonidine (CLO) drug and its determination, using an unmodified glassy carbon electrode…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis by de A. Simoes Moreira, Debora, Gauer, Luís Eduardo, Teixeira, Guilherme, Fonseca da Silva, Amanda Carolina, Cavalcanti, Stefanie, Quevedo, João

    Published in Journal of affective disorders (01-06-2023)
    “…ECT is considered the fastest and most effective treatment for TRD. Ketamine seems to be an attractive alternative due to its rapid-onset antidepressant…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Potential of Dendrimers as Alzheimer’s Disease Nanotherapeutics – Evidence of Antiamyloidogenic Properties Against Aβ42 by Moreira, Débora A., Santos, Sofia D., Leiro, Victoria, Pêgo, Ana P.

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Today, available therapies for Alzheimer’s disease (AD) fail to modify the disease progression for the major AD clinical stages [1]. Therefore, new…”
    Get full text
    Journal Article
  8. 8